Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid in Type 2 Diabetes with Peripheral Neuropathy
NCT04322240Completed
- Sponsor
- Benha University
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alpha-lipoic acid in diabetic peripheral neuropathy (DPN), sponsored by Benha University. Primary endpoints: Monofilament test of both feet at 3 months, Vibration Perception Threshold at 3 months and 8 more. Started Apr 2020; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04322240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322240.